BrainChild Bio is a clinical-stage biotechnology company developing CAR-T cell therapies for tumors in the central nervous system. Its kids-first platform prioritizes pediatric brain tumors, including diffuse intrinsic pontine glioma (DIPG), with plans to expand into additional pediatric and adult CNS tumor indications.
Leadership & Board
Key Executives
Foundermichael jensen
Current Number of Employees55
Current LinkedIn Followers5,195
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$116M
Total Amount Raised$116M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$116M
Latest Funding Amount$116M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 09, 2026
Series A
$116.00M
―
Similar Companies
A snapshot of private companies similar to BrainChild Bio, helping you discover and navigate related company profiles.